Community-based infections and its association with mental disorder onset: a nationwide matched cohort study
Most studies assessing the association between infection accumulation and mental disorders focus on hospitalization-based severe infections. However, most infections are more common, and community acquired. This study aimed to evaluate the effects of community-based infection accumulation on risk to develop a mental disorder, and risk factors modulating this association. A nationwide population-based matched cohort study was conducted, utilizing the registries of Clalit Health Services, the largest healthcare organization in Israel. Individuals born between the years 1995–2005 with history of specific infections (n = 35 020) were propensity score matched to an unexposed group with no such history (n = 35 020). These individuals were followed up until 2024 for a mental disorder onset. Serology, nasal and saliva-based tests for cytomegalovirus, herpesviruses, hepatitis, influenza, or toxoplasma gondii starting from birth were identified, and patients were followed for onset of anxiety, depression schizophrenia and bipolar disorders. Individuals with history of infection accumulation demonstrated higher risk to develop a mental disorder, with risk gradually increasing after one (HR, 1.08, 95%CI, 1.01–1.17, p = 0.036), two (HR, 1.19, 95%CI, 1.09–1.30, p < 0.001) and three or more infections (HR, 1.81, 95%CI, 1.32–2.48, p < 0.001) up to first five years post-infection. These associations were stronger in females, individuals of older age and individuals with larger families. The findings suggest that community-based immune challenges might shape vulnerability for mental disorders, and stress the need to consider infection history in future efforts to develop patient-tailored prevention and intervention strategies.
Authors
- Dimitrios Andreou (ORCID: https://orcid.org/0000-0003-4735-3383)
- Yonat Shemer Avni (ORCID: https://orcid.org/0000-0002-3668-9060)
- Arnon Dov Cohen (ORCID: https://orcid.org/0000-0002-8377-9982)
- Nils Eiel Steen (ORCID: https://orcid.org/0000-0001-6442-1179)
- Ole A. Andreassen (ORCID: https://orcid.org/0000-0002-4461-3568)
- Helga Ask (ORCID: https://orcid.org/0000-0003-0149-5319)
- Amit Kramer (ORCID: https://orcid.org/0000-0002-3404-818X)
- Chloë Trippaers (ORCID: https://orcid.org/0000-0001-7917-9311)
- Federica Colombo (ORCID: https://orcid.org/0000-0001-5853-9912)
- Ingrid Torp Johansen (ORCID: https://orcid.org/0000-0001-7976-1395)
- Francesco Benedetti (ORCID: https://orcid.org/0000-0003-4949-856X)
- Orly Weinstein (ORCID: https://orcid.org/0000-0002-7913-513X)
- Violette Coppens (ORCID: https://orcid.org/0000-0001-6247-551X)
- Benedetta Vai (ORCID: https://orcid.org/0000-0002-0748-4656)
- Dana Tzur Bitan (ORCID: https://orcid.org/0000-0002-7948-9616)
- Sara Poletti (ORCID: https://orcid.org/0000-0001-9594-0246)
- Marco Paolini (ORCID: https://orcid.org/0000-0001-5731-5925)
- Or Keynan
- Noga Givon-Lavi
- Amit Nachman
- Livia De Picker
Institutions
- Ben-Gurion University of the Negev (IL)
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- University of Antwerp (BE)
- Vita-Salute San Raffaele University (IT)
- University of Oslo (NO)
- Sheba Medical Center (IL)
- Soroka Medical Center (IL)
- Diakonhjemmet Hospital (NO)
- IRCCS Ospedale San Raffaele (IT)
- Shalvata Mental Health Center (IL)
- Clalit Health Services (IL)
- University of Haifa (IL)
Publication Details
- Journal
- Translational Psychiatry
- Published
- 2026-08-17
- DOI
- https://doi.org/10.1038/s41398-026-04384-w
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Norges Forskningsråd
- Office of the Chief Scientist, Ministry of Health
- European College of Neuropsychopharmacology
- Horizon 2020 Framework Programme